Tirzepatide vs Semaglutide: Which GLP-1 is Right for You?

Two medications dominate the medical weight loss conversation right now: semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound). Both active pharmaceutical ingredients have been studied in FDA-approved formulations. But which one may be right for you? Here's a complete, honest comparison.

The Key Difference: How They Work

Both medications are GLP-1 receptor agonists — they mimic the GLP-1 hormone to reduce appetite and regulate blood sugar. The critical difference is that tirzepatide also activates the GIP (glucose-dependent insulinotropic polycompound) receptor, making it a dual-action medication.

This dual mechanism appears to produce greater weight loss in most patients — but both active pharmaceutical ingredients have demonstrated results in studies of FDA-approved formulations.

Head-to-Head: What the Research Shows

Semaglutide (Wegovy / Ozempic)

• Average weight loss: 14.9% of body weight (STEP 1 trial)
• Dosing: Once weekly injection, or daily oral tablet
• FDA-approved for chronic weight management (Wegovy)
• Longest safety track record of the two
• Starting price at Zera Health: from $194/mo

Tirzepatide (Mounjaro / Zepbound)

• Average weight loss: 20.9% of body weight (SURMOUNT-1 trial)
• Some patients lose up to 22% — greater than any previously approved weight loss medication
• Dosing: Once weekly injection
• FDA-approved for chronic weight management (Zepbound, 2023)
• Starting price at Zera Health: from $149/mo

Side Effects Comparison

Both medications share a similar side effect profile since they share the GLP-1 mechanism:

• Nausea (most common, especially early on)
• Constipation or diarrhea
• Reduced appetite
• Mild fatigue

Studies suggest tirzepatide may cause slightly more nausea at higher doses, but the profiles are very similar overall. Starting low and titrating slowly minimizes side effects for both.

Which Should You Choose?

Start with semaglutide if:

• You want the medication with the longest track record
• Cost is a consideration your provider can discuss
• You prefer a daily oral option (compounded oral semaglutide available)
• You have prior experience with GLP-1 medications

Consider tirzepatide if:

• You want maximum weight loss potential
• You have type 2 diabetes alongside obesity
• You've tried semaglutide with limited results
• Your provider recommends it based on your health profile

What Your Provider Will Consider

Your Zera Health provider will evaluate your health history, BMI, any existing conditions, medications, and goals before recommending the right GLP-1 for you. There's no one-size-fits-all answer — the best medication is the one that fits your clinical profile and lifestyle.